Legend Biotech Corp ADR (LEGN): Next-Year EPS Estimate 3802.71%
As of 2026-09-18, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 3802.71%. Featured in 3 EPS revision reports, most recently on 2026-04-23.
On 2026-09-11, analyst consensus for LEGN's next-year EPS growth shifted from 8426.45% to 3802.71% — a negative change of 4623.74 percentage points. The revised estimate has been sustained across 7 subsequent trading sessions. Current-year growth is projected at 98.01%.
What's Driving This
LEGN’s rise is primarily driven by a large upward revision to next-year EPS growth estimates, with analysts lifting the figure from 14,867.72% to 8,426.45% on 2026-08-19. No specific catalyst, such as an earnings beat or product launch, appears in recent headlines to explain the upgrade. The only related news mentions Johnson & Johnson retaining stakes in rumored acquisition targets, which does not clearly connect to the revision. Thus, the move likely reflects the estimate adjustment itself rather than a named fundamental event.
Generated 2026-09-09 from news as of 2026-09-09
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 3802.71%
- EPS growth this year
- 98.01%
- EPS next quarter (est)
- $0.00
- Last price
- $17.61
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-09-18 | 3802.71% | 98.01% | $0.00 | $17.61 |
| 2026-09-17 | 3802.71% | 98.01% | $0.00 | $17.58 |
| 2026-09-16 | 3802.71% | 98.01% | $0.00 | $17.00 |
| 2026-09-15 | 3802.71% | 98.01% | $0.00 | $17.67 |
| 2026-09-14 | 3802.71% | 98.01% | $0.00 | $18.53 |
| 2026-09-13 | 3802.71% | 98.01% | $0.00 | $18.64 |
| 2026-09-11 | 3802.71% | 98.01% | $0.00 | $18.64 |
| 2026-09-10 | 8426.45% | 99.08% | $0.01 | $19.19 |
| 2026-09-09 | 8426.45% | 99.08% | $0.01 | $19.91 |
| 2026-09-08 | 8426.45% | 99.08% | $0.01 | $20.49 |
| 2026-09-07 | 8426.45% | 99.08% | $0.01 | $21.52 |
| 2026-09-06 | 8426.45% | 99.08% | $0.01 | $21.52 |
| 2026-09-04 | 8426.45% | 99.08% | $0.01 | $21.52 |
| 2026-09-03 | 8426.45% | 99.08% | $0.01 | $21.75 |
| 2026-09-02 | 8426.45% | 99.08% | $0.01 | $21.89 |
| 2026-09-01 | 8426.45% | 99.08% | $0.01 | $21.13 |
| 2026-08-31 | 8426.45% | 99.08% | $0.01 | $20.78 |
| 2026-08-30 | 8426.45% | 99.08% | $0.01 | $19.88 |
| 2026-08-29 | 8426.45% | 99.08% | $0.01 | $19.88 |
| 2026-08-28 | 8426.45% | 99.08% | $0.01 | $19.88 |
| 2026-08-27 | 8426.45% | 99.08% | $0.01 | $20.50 |
| 2026-08-26 | 8426.45% | 99.08% | $0.01 | $20.68 |
| 2026-08-25 | 8426.45% | 99.08% | $0.01 | $21.30 |
| 2026-08-24 | 8426.45% | 99.08% | $0.01 | $20.94 |
| 2026-08-23 | 8426.45% | 99.08% | $0.01 | $21.82 |
| 2026-08-21 | 8426.45% | 99.08% | $0.01 | $21.82 |
| 2026-08-20 | 8426.45% | 99.08% | $0.01 | $21.26 |
| 2026-08-19 | 8426.45% | 99.08% | $0.01 | $22.60 |
| 2026-08-18 | 14867.72% | 99.47% | $0.01 | $21.92 |
| 2026-08-17 | 14867.72% | 99.47% | $0.01 | $20.65 |
Reports Featuring LEGN
Recent News
Screen Performance
Aggregate stats across all 2047 tickers our top-EPS-revision screen has flagged over the past 170 days.
- Median return since detection
- +0.3%
- % of tickers in the green
- 51%
- Median return on winners
- +22.2%
- Large revisions captured
- 1736
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Legend Biotech Corp ADR's next-year EPS growth estimate?▾
As of 2026-09-18, Legend Biotech Corp ADR (LEGN) has a next-year EPS growth estimate of 3802.71%, based on analyst consensus.
When was the latest EPS estimate revision for LEGN?▾
The most recent revision occurred on 2026-09-11, when analysts adjusted the next-year EPS growth estimate from 8426.45% to 3802.71%.
What sector and industry does Legend Biotech Corp ADR belong to?▾
Legend Biotech Corp ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. LEGN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Legend Biotech Corp ADR (LEGN) appears here because it was detected by our daily top-EPS-revision-performer screen.